Best Large Cap Stocks this February 2026

Chevron Corporation stands out as a top-rated energy company with a market cap of $250.3 billion, offering investors a compelling fair value upside potential of 24.2%. With a robust dividend yield of 4.45%, it promises reliable income alongside impressive long-term returns, boasting a 5-year gain of 91.67%. Analysts are optimistic, assigning a median 12-month price target of $174.00, reflecting strong confidence in its growth trajectory.

Exxon Mobil Corporation stands out as a solid investment, boasting a market cap of $462 billion and an attractive 3.35% dividend yield. With a remarkable 1-year return of 24.20% and an impressive 5-year return of 201.72%, it appeals to investors seeking reliable income and growth potential. Analysts maintain a strong outlook, setting a median 12-month price target of $142.00, and consistently rating the stock as Overweight, indicating confidence in its long-term profitability and shareholder value growth.

We anticipate that XOM's earnings, cash flow, and return on capital will significantly outperform competitors through 2030, supporting strong shareholder value growth.

XOM's stock decline is driven by weak commodity prices, margin pressures, revised earnings guidance, and technical selling after breaking support levels.

Taiwan Semiconductor Manufacturing Company (TSMC) stands as a premier semiconductor manufacturer with a remarkable market cap of $1.4 trillion and a striking 75.93% return over the past year. Analysts maintain a strong outlook, reflected in a median 12-month price target of $405.00, supported by a Buy rating from Needham and an Overweight stance from Barclays. With a dividend yield of 0.79% and expectations of continued growth into 2026, TSMC represents a solid investment opportunity for those seeking reliable income from financially healthy companies.

TSM is expected to maintain strong growth through 2026, making it a solid investment, especially with the recent 20% dividend increase.

Alibaba Group Holding Limited stands out as a compelling investment opportunity, boasting a market cap of $276.6 billion and a promising 36.4% fair value upside. Investors can benefit from a dividend yield of approximately 1.7% and have witnessed impressive one-year returns of nearly 92%. Analysts maintain a median price target of $190.00, with a favorable B+ rating reflecting confidence in the company's recovery and growth potential.

Alibaba Group Holding Limited (BABA) is currently trading near its 52-week high and above its 200-day moving average, but shares have decreased by $1.66, or 0.96%, since the last market close.

Alibaba may be considered a value trap, as its low valuation is based on the assumption that its previous high-leverage growth strategy can be replicated, which is unlikely from both macro and micro perspectives.

Merck & Co., Inc., a healthcare giant with a market cap of $204.3 billion, stands out for its potential upside of 33.4% relative to fair value. With a solid dividend yield of 3.27% and impressive long-term returns—46.83% over five years—investors are encouraged by its consistent performance and strong analyst ratings, including a median price target of $120.00.

Analysts estimate that Merck could reach approximately $111 per share by 2027, indicating a potential upside of about 28% from current levels, or roughly 12% annualized returns.

Johnson & Johnson stands out as a pharmaceutical leader with a market cap of $376.4 billion, showcasing a promising 12.7% upside potential. With a dividend yield of 2.32% and a remarkable 1-year return of 46.78%, this stock is particularly appealing for investors seeking reliable income from financially healthy companies. Analysts maintain a cautious outlook with a median 12-month price target of $220.00, supported by strong ratings from firms like Guggenheim and Wells Fargo.

The highest closing price for Johnson & Johnson stock was $219.57 on January 15, 2026, while the 52-week high is $220.11.

Johnson & Johnson's earnings per share (EPS) growth is expected to remain steady, with projections of $12 in operating earnings per share by mid-2026, although sales growth is anticipated to be in the mid-single digits.

For full-year 2026, J&J expects profits between $11.43 and $11.63 per share, with analysts forecasting an average of $11.45 per share.

S&P Global Inc. stands out as a financial services giant, operating within a duopoly and boasting a market cap of $161 billion. With a solid dividend yield of 0.73% and impressive long-term returns—71.95% over the past five years—this stock presents a compelling opportunity for investors seeking growth. Analysts have set a median 12-month price target of $629.50, reflecting strong growth potential despite recent downturns.

SPGI has strong growth potential, with an estimated stock price growth of 16.30%, making it an attractive option for long-term investors.

S&P Global's earnings per share (EPS) grew at a compounded annual growth rate of 20% over the last two years, indicating improved profitability.

The consensus rating from 17 Wall Street analysts for SPGI is 'Buy,' with 16 analysts recommending a buy and 1 recommending a strong buy.